Gov. Henry McMaster's pick to lead the state health department said he was abusively threatened and had his car vandalized ...

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new ...

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years ...

Researchers have identified antibodies that could lead to a broadly protective norovirus vaccine and new treatment options.

Multiple allergy forecasters indicate 2025 is likely to be a pretty rough year for seasonal allergies. Pollen counts are ...

Spring allergy season is ramping up and doctors in North Carolina say the state is one of the worst areas in the country when it comes to allergies.

But there's a silver lining, officials say: More people have received a measles, mumps and rubella vaccination this year in ...

The changing therapeutic landscape for urticaria, angioedema, and anaphylaxis is evidenced by emerging treatments reported at ...

the former physician and immunologist who served as the director of the National Institute of Allergy and Infectious Diseases during the pandemic. Fauci has become a target of the far right and ...

North Carolina, told Medscape Medical News. Berchuck was not involved in the clinical trial. The National Cancer Institute lists adjuvant chemotherapy first in its guidelines for this group.

H5N1 influenza is evolving rapidly, weakening the effectiveness of existing antibodies and increasing its potential threat to ...

Daily science news on research developments and the latest scientific innovations Science X Daily and the Weekly Email Newsletter are free features that allow you to receive your favorite sci-tech ...